The global ENT devices market size is expected to reach USD 37.72 billion by 2030, registering a CAGR of 5.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as a rising geriatric population, high prevalence of hearing loss, and increasing penetration of minimally invasive surgeries. Technological advancements in this field, an increase in healthcare investment for early detection of diseases, and favorable regulatory policies are other factors expected to drive the market’s growth.
The risk of poor immunity increases with age, making older people more vulnerable to disorders of the nose and throat. To address this issue, elderly people need regular check-ups for ENT disorders, which is leading to a rise in demand for ENT devices. According to the Royal National Institute for Deaf People (RNID), over 12 million people in the UK suffered from hearing loss. Out of these, over 40% of people were in the 50s & above, and more than 70% of people were in the 70s & above.
Hearing loss is a common chronic physical condition affecting the people of all ages. It is the third-most common condition after high blood pressure and arthritis. It is more prevalent in elder population, particularly in people over 65 years of age, and 1 in 3 people are likely to suffer from a disabling hearing loss. It can negatively impact communication and leading to depression, anxiety, social isolation, and cognitive decline. According to the National Institute on Deafness and Other Communication Disorders, 15% of the total U.S. population over 18 years of age are likely to have a hearing impairment. In addition, men are more likely to be affected with hearing loss than women.
Request a free sample copy or view report summary: ENT Devices Market Report
The hearing aids segment dominated the market in 2024 and accounted for the largest revenue share of 31.06% and is also anticipated to register the fastest growth rate over the forecast period.
The surgical ENT devices segment is anticipated to register a considerable growth rate over the forecast period.
North America dominated the ENT devices industry in 2024 and accounted for the largest revenue share of 34.99%. Key factors contributing to growth of this region are growing geriatric population and increasing prevalence of hearing loss.
The ENT devices market in the U.S. held the largest share of 90.35% in 2024 due to technological advancements and recent approvals received for several hearing devices.
Asia Pacific is anticipated to be the significantly growing region in the market.Technological innovations, such as real-time monitoring, wireless technology, increase in healthcare spending in the Asia Pacific region.
Grand View Research has segmented global ENT devices market report on the basis of product and region:
ENT Devices Product Outlook (Revenue USD Million, 2018 - 2030)
Diagnostic ENT Devices
Rigid Endoscopes
Sinuscopes
Otoscopes
Laryngoscopes
Flexible Endoscopes
Bronchoscopes
Laryngoscopes
Nasopharyngoscopes
Robot Assisted Endoscope
Hearing Screening Device
Surgical ENT Devices
Radiofrequency handpieces
Otological Drill Burrs
ENT Hand Instruments
Sinus Dilation Devices
Nasal Packing Devices
Others
Hearing Aids
Hearing Implants
Nasal Splints
ENT Devices Regional Outlook Revenue USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
Italy
France
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of ENT Devices Market
Ambu A/S
Cochlear Ltd.
Demant A/S
Sonova
GN Store Nord A/S
Karl Storz
Olympus Corporation
PENTAX Medical
Richard Wolf GmbH
Rion Co., Ltd.
Smith & Nephew plc
Starkey Laboratories, Inc.
Stryker
MED-EL Medical Electronics
Nemera
"The quality of research they have done for us has been excellent..."